Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$84.3 - $94.31 $28,577 - $31,971
339 Added 9.96%
3,742 $345,000
Q1 2024

May 09, 2024

BUY
$72.54 - $95.56 $16,103 - $21,214
222 Added 6.98%
3,403 $325,000
Q4 2023

Feb 05, 2024

SELL
$61.71 - $77.76 $1,542 - $1,944
-25 Reduced 0.78%
3,181 $242,000
Q3 2023

Oct 25, 2023

SELL
$69.28 - $93.38 $12,747 - $17,181
-184 Reduced 5.43%
3,206 $222,000
Q2 2023

Jul 31, 2023

BUY
$81.41 - $94.33 $46,892 - $54,334
576 Added 20.47%
3,390 $319,000
Q1 2023

May 08, 2023

BUY
$74.26 - $84.51 $208,967 - $237,811
2,814 New
2,814 $232,000
Q3 2022

Nov 09, 2022

BUY
$82.37 - $107.29 $6,095 - $7,939
74 Added 3.1%
2,462 $203,000
Q2 2022

Aug 04, 2022

BUY
$86.5 - $128.27 $4,930 - $7,311
57 Added 2.45%
2,388 $227,000
Q1 2022

May 13, 2022

BUY
$101.96 - $128.34 $9,176 - $11,550
90 Added 4.02%
2,331 $274,000
Q4 2021

Feb 03, 2022

BUY
$106.37 - $130.68 $3,084 - $3,789
29 Added 1.31%
2,241 $290,000
Q3 2021

Nov 04, 2021

BUY
$102.91 - $122.75 $6,380 - $7,610
62 Added 2.88%
2,212 $250,000
Q2 2021

Aug 10, 2021

BUY
$83.84 - $104.76 $180,256 - $225,234
2,150 New
2,150 $223,000
Q4 2020

Feb 10, 2021

SELL
$71.69 - $91.23 $217,865 - $277,247
-3,039 Closed
0 $0
Q3 2020

Nov 12, 2020

BUY
$67.19 - $87.44 $4,232 - $5,508
63 Added 2.12%
3,039 $243,000
Q2 2020

Aug 11, 2020

BUY
$57.54 - $76.95 $108,750 - $145,435
1,890 Added 174.03%
2,976 $206,000
Q1 2020

May 13, 2020

BUY
$52.41 - $81.0 $419 - $648
8 Added 0.74%
1,086 $205,000
Q4 2019

Feb 07, 2020

SELL
$71.7 - $82.09 $2,581 - $2,955
-36 Reduced 3.23%
1,078 $251,000
Q3 2019

Oct 28, 2019

BUY
$61.55 - $75.43 $68,566 - $84,029
1,114 New
1,114 $245,000
Q2 2019

Aug 05, 2019

SELL
$55.74 - $64.41 $66,497 - $76,841
-1,193 Closed
0 $0
Q1 2019

Apr 26, 2019

BUY
$47.89 - $64.05 $57,132 - $76,411
1,193 New
1,193 $228,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Brighton Jones LLC Portfolio

Follow Brighton Jones LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brighton Jones LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brighton Jones LLC with notifications on news.